首页|期刊导航|Oncology Research|Immune landscape of neoadjuvant chemoradiotherapy:involvement of MAL,a T-cell differentiation protein

Immune landscape of neoadjuvant chemoradiotherapy:involvement of MAL,a T-cell differentiation protein

KOSEI NAKAJIMA YOSHINORI INO

Oncology Research2025，Vol.33Issue(7)：P.1769-1779,11.

Oncology Research2025，Vol.33Issue(7)：P.1769-1779,11.DOI:10.32604/or.2025.063419

Immune landscape of neoadjuvant chemoradiotherapy:involvement of MAL,a T-cell differentiation protein

KOSEI NAKAJIMA ¹YOSHINORI INO²

作者信息

1. Division of Molecular Pathology,National Cancer Center Research Institute,5-1-1 Tsukiji,Chuo-ku,104-0045,Tokyo Japan Division of Translational Research,Exploratory Oncology Research&Clinical Trial Center,National Cancer Center,5-1-1 Tsukiji,Chuo-ku,104-0045,Tokyo Japan Division of Surgery,Faculty of Veterinary Medicine,Imabari Campus,Okayama University of Science,1-3 Ikoinooka,Imabari,794-8555,Ehime Japan
2. Division of Molecular Pathology,National Cancer Center Research Institute,5-1-1 Tsukiji,Chuo-ku,104-0045,Tokyo Japan
折叠

摘要

关键词

Neoadjuvant/preoperative therapy(NAT)/Anti-tumor immunity/T-cell differentiation

分类

医药卫生

引用本文复制引用

KOSEI NAKAJIMA,YOSHINORI INO..Immune landscape of neoadjuvant chemoradiotherapy:involvement of MAL,a T-cell differentiation protein[J].Oncology Research,2025,33(7):P.1769-1779,11.

基金项目

supported by JSPS KAKENHI,grant number 18K16377(KN). （KN）

Oncology Research

ISSN：0965-0407

访问量0

下载量0

段落导航